Citius Pharmaceuticals, Inc. (CTXR)

Track CTXR Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Get Citius Pharma news, earnings, and stock analysis — all in one place at TipRanks.

Following the last earnings report on May 15, 2026, Citius Pharmaceuticals (CTXR)'s stock price moved — from — to —.

Analysts average stock forecasts to be materialized ratio is 15.87% with an average time for these price targets to be met of 503 days. Highest price target for CTXR is $6, Lowest price target is $6, average price target is $6.

Citius Oncology (CTOR), an ... (CTXR) announced positive topline safety... ... Citius Oncology, Inc. lowest stock price was $0.49 and its highest was $5.89 in the past 12 months. ... Citius Oncology, Inc.’s market cap is $60.45M. When is Citius Oncology, Inc.’s upcoming earnings report ...

Looking to buy Citius Pharmaceuticals Stock? Get the latest CTXR quote, news, earnings, forecast, price targets, and market insights. Start investing on Public.com.